# ARID5B

## Overview
ARID5B is a gene that encodes the AT-rich interaction domain 5B protein, a transcription factor involved in various cellular processes, including transcriptional regulation, metabolism, and cell differentiation. The ARID5B protein is characterized by its ARID domain, a DNA-binding domain that facilitates its role in gene regulation, and a BAH domain that may contribute to chromatin interactions (Korn2022Structures). Functionally, ARID5B is crucial in B cell development, energy regulation, and metabolic processes, influencing both fatty acid and glucose metabolism (Chalise2023ARID5B; Goodings2020<i>ARID5B<i>). Clinically, ARID5B is significant due to its association with acute lymphoblastic leukemia (ALL) and other cancers, where genetic variations can affect disease susceptibility and treatment outcomes (Zhou2019ARID5BGenetic; Wang2020The). The protein's interactions with other transcription factors and histone modifiers underscore its role in transcriptional regulation and its potential impact on oncogenesis and metabolic disorders (Leong2017ARID5B; Hata2013Arid5b).

## Structure
The ARID5B protein contains an ARID domain, which is a DNA-binding domain approximately 100 amino acids long. This domain is characterized by a helix-turn-helix (HTH) motif, consisting of six α-helices (H1-H6) and two loops (L1 and L2), with the L2 loop being atypically long. The ARID domain can be extended by additional helices, such as H0 and H7, which may influence DNA-binding affinity and specificity (von20231H; Korn2022Structures).

The ARID5B protein is predicted to have an additional BAH domain at its N-terminus, which is common in chromatin-interacting proteins. This domain may contribute to the protein's tertiary structure and its interaction with chromatin (Korn2022Structures). The ARID domain's tertiary structure is stabilized by a hydrophobic core, crucial for DNA binding and thermal stability, with a valine residue playing a significant role (Korn2022Structures).

While specific details on the quaternary structure of ARID5B are not provided, the presence of conserved residues and domain extensions suggests potential interactions with other proteins or nucleic acids, impacting its functional role in transcriptional regulation (Korn2022Structures).

## Function
The ARID5B gene encodes a transcription factor that plays a significant role in various cellular processes, including B cell development, fatty acid metabolism, and energy regulation. In the context of B cell development, ARID5B is crucial during the pre-B cell stage, where it regulates the transition from large proliferative pre-B cells to non-proliferative small pre-B cells, facilitating their differentiation into immature B cells (Chalise2023ARID5B). It achieves this by limiting cell proliferation and influencing fatty acid metabolism, primarily by inhibiting fatty acid uptake and oxidation (Chalise2023ARID5B).

ARID5B also plays a role in regulating glucose metabolism and mitochondrial oxidative phosphorylation. It forms complexes with other proteins to activate genes involved in glucose metabolism, impacting processes like glycolysis and oxidative phosphorylation in various cell types, including adipocytes and muscle cells (Goodings2020<i>ARID5B<i>; Okazaki2020Increased). In skeletal muscle, ARID5B influences fuel utilization by modulating fatty acid and glucose metabolism, which affects systemic energy balance and metabolic flexibility (Murray2023Musclespecific). These functions highlight ARID5B's role in maintaining normal cellular and organismal homeostasis.

## Clinical Significance
The ARID5B gene is clinically significant due to its association with various diseases, particularly acute lymphoblastic leukemia (ALL). Genome-wide association studies have identified ARID5B as a significant locus linked to ALL susceptibility, with specific single nucleotide polymorphisms (SNPs) such as rs10821936 being associated with increased risk, especially in childhood ALL (Wang2020The; Guo2013ARID5B). Variants in ARID5B are linked to poorer treatment outcomes, including higher relapse rates and drug resistance, particularly to antimetabolite drugs like mercaptopurine and methotrexate (Wang2020The).

ARID5B is also implicated in other cancers, such as endometrial, gastric, and prostate cancers, where its mutations and expression levels affect disease progression and treatment resistance (Wang2020The). In chronic lymphocytic leukemia (CLL), ARID5B overexpression is linked to fludarabine resistance through the MAPK pathway (Wang2020The).

In acute myeloid leukemia (AML), particularly acute promyelocytic leukemia (APL), ARID5B polymorphisms are associated with increased susceptibility and are considered independent prognostic factors (Zhou2019ARID5BGenetic). The gene's expression is also linked to metabolic disorders, affecting adipogenesis and insulin sensitivity (Wang2020The).

## Interactions
ARID5B interacts with various proteins and nucleic acids, playing a significant role in transcriptional regulation. It forms a complex with plant homeodomain finger protein 2 (PHF2), a histone demethylase, to demethylate dimethylated Lys 9 on histone H3 (H3K9me2), facilitating transcription activation of target genes. This interaction is crucial in processes such as adipogenesis, liver development, and chondrogenesis, where it acts as a co-activator of hepatocyte nuclear factor 4α (HNF4α) and modulates H3K9me2 levels of chondrocyte marker gene promoters (Hata2013Arid5b; Wang2020The).

ARID5B also interacts with the transcription factor Sox9, enhancing Sox9-dependent chondrocyte differentiation by recruiting PHF2 to Sox9-regulated genes. This interaction is mediated through the C terminus of ARID5B, and it is essential for promoting the expression of chondrogenic markers like Col2a1 and Aggrecan (Hata2013Arid5b).

In T-cell acute lymphoblastic leukemia (T-ALL), ARID5B is a critical downstream target of the TAL1 complex, interacting with transcription factors such as TAL1, GATA3, RUNX1, and ETS1. It binds to promoters and enhancers with active histone marks, regulating the expression of oncogenes like MYC (Leong2017ARID5B).


## References


[1. (Leong2017ARID5B) Wei Zhong Leong, Shi Hao Tan, Phuong Cao Thi Ngoc, Stella Amanda, Alice Wei Yee Yam, Wei-Siang Liau, Zhiyuan Gong, Lee N. Lawton, Daniel G. Tenen, and Takaomi Sanda. Arid5b as a critical downstream target of the tal1 complex that activates the oncogenic transcriptional program and promotes t-cell leukemogenesis. Genes &amp; Development, 31(23–24):2343–2360, December 2017. URL: http://dx.doi.org/10.1101/gad.302646.117, doi:10.1101/gad.302646.117. This article has 49 citations.](https://doi.org/10.1101/gad.302646.117)

[2. (Wang2020The) Peiqi Wang, Yun Deng, Xinyu Yan, Jianhui Zhu, Yuanyuan Yin, Yang Shu, Ding Bai, Shouyue Zhang, Heng Xu, and Xiaoxi Lu. The role of arid5b in acute lymphoblastic leukemia and beyond. Frontiers in Genetics, June 2020. URL: http://dx.doi.org/10.3389/fgene.2020.00598, doi:10.3389/fgene.2020.00598. This article has 25 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fgene.2020.00598)

[3. (Okazaki2020Increased) Yuri Okazaki, Jennifer Murray, Ali Ehsani, Jessica Clark, Robert H. Whitson, Lisa Hirose, Noriyuki Yanaka, and Keiichi Itakura. Increased glucose metabolism in arid5b−/− skeletal muscle is associated with the down-regulation of tbc1 domain family member 1 (tbc1d1). Biological Research, October 2020. URL: http://dx.doi.org/10.1186/s40659-020-00313-3, doi:10.1186/s40659-020-00313-3. This article has 14 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s40659-020-00313-3)

[4. (Zhou2019ARID5BGenetic) Juan Zhou, Haimei Gou, Li Zhang, Xinyi Wang, Yuanxin Ye, Xiaojun Lu, and Binwu Ying. Arid5bgenetic polymorphisms contribute to the susceptibility and prognosis of male acute promyelocytic leukemia. DNA and Cell Biology, 38(11):1374–1386, November 2019. URL: http://dx.doi.org/10.1089/dna.2019.4926, doi:10.1089/dna.2019.4926. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.1089/dna.2019.4926)

[5. (von20231H) Julian von Ehr, Sophie Marianne Korn, Lena Weiß, and Andreas Schlundt. 1h, 13c, 15n backbone chemical shift assignments of the extended arid domain in human at-rich interactive domain protein 5a (arid5a). Biomolecular NMR Assignments, 17(1):121–127, May 2023. URL: http://dx.doi.org/10.1007/s12104-023-10130-w, doi:10.1007/s12104-023-10130-w. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s12104-023-10130-w)

[6. (Guo2013ARID5B) Lei-Ming Guo, Jia-Shui Xi, Yan Ma, Lin Shao, Cui-Li Nie, and Guang-Jun Wang. Arid5b gene rs10821936 polymorphism is associated with childhood acute lymphoblastic leukemia: a meta-analysis based on 39,116 subjects. Tumor Biology, 35(1):709–713, August 2013. URL: http://dx.doi.org/10.1007/s13277-013-1097-0, doi:10.1007/s13277-013-1097-0. This article has 18 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s13277-013-1097-0)

[7. (Korn2022Structures) Sophie Marianne Korn and Andreas Schlundt. Structures and nucleic acid-binding preferences of the eukaryotic arid domain. Biological Chemistry, 403(8–9):731–747, February 2022. URL: http://dx.doi.org/10.1515/hsz-2021-0404, doi:10.1515/hsz-2021-0404. This article has 12 citations and is from a peer-reviewed journal.](https://doi.org/10.1515/hsz-2021-0404)

[8. (Hata2013Arid5b) Kenji Hata, Rikako Takashima, Katsuhiko Amano, Koichiro Ono, Masako Nakanishi, Michiko Yoshida, Makoto Wakabayashi, Akio Matsuda, Yoshinobu Maeda, Yutaka Suzuki, Sumio Sugano, Robert H. Whitson, Riko Nishimura, and Toshiyuki Yoneda. Arid5b facilitates chondrogenesis by recruiting the histone demethylase phf2 to sox9-regulated genes. Nature Communications, November 2013. URL: http://dx.doi.org/10.1038/ncomms3850, doi:10.1038/ncomms3850. This article has 74 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/ncomms3850)

[9. (Chalise2023ARID5B) Jaya Prakash Chalise, Ali Ehsani, Mengistu Lemecha, Yu-Wen Hung, Guoxiang Zhang, Garrett P. Larson, and Keiichi Itakura. Arid5b regulates fatty acid metabolism and proliferation at the pre-b cell stage during b cell development. Frontiers in Immunology, July 2023. URL: http://dx.doi.org/10.3389/fimmu.2023.1170475, doi:10.3389/fimmu.2023.1170475. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fimmu.2023.1170475)

[10. (Murray2023Musclespecific) Jennifer Murray, Ali Ehsani, Liza Najjar, Guoxiang Zhang, and Keiichi Itakura. Muscle-specific deletion of arid5b causes metabolic changes in skeletal muscle that affect adipose tissue and liver. Frontiers in Endocrinology, January 2023. URL: http://dx.doi.org/10.3389/fendo.2022.1083311, doi:10.3389/fendo.2022.1083311. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fendo.2022.1083311)